Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Cyclerion Therapeutics (CYCN) Leases (2019 - 2023)

Cyclerion Therapeutics (CYCN) has 5 years of Leases data on record, last reported at $1.1 million in Q2 2023.

  • For Q2 2023, Leases fell 14.12% year-over-year to $1.1 million; the TTM value through Jun 2023 reached $1.1 million, down 14.12%, while the annual FY2022 figure was $1.2 million, 13.12% down from the prior year.
  • Leases reached $1.1 million in Q2 2023 per CYCN's latest filing, down from $1.2 million in the prior quarter.
  • Across five years, Leases topped out at $70.3 million in Q2 2019 and bottomed at $1.1 million in Q2 2023.
  • Average Leases over 5 years is $26.9 million, with a median of $6.3 million recorded in 2021.
  • The widest YoY moves for Leases: up 12.77% in 2022, down 96.8% in 2022.
  • A 5-year view of Leases shows it stood at $68.1 million in 2019, then plummeted by 36.3% to $43.4 million in 2020, then tumbled by 96.77% to $1.4 million in 2021, then decreased by 13.12% to $1.2 million in 2022, then fell by 7.64% to $1.1 million in 2023.
  • Per Business Quant database, its latest 3 readings for Leases were $1.1 million in Q2 2023, $1.2 million in Q1 2023, and $1.2 million in Q4 2022.